PLEKHJ1
gene geneOn this page
Also known as FLJ10297
Summary
PLEKHJ1 (pleckstrin homology domain containing J1, HGNC:18211) is a protein-coding gene on chromosome 19p13.3, encoding Pleckstrin homology domain-containing family J member 1 (Q9NW61).
Predicted to be involved in endosome organization; receptor recycling; and retrograde transport, endosome to Golgi. Predicted to be located in Golgi apparatus; cytoplasmic vesicle; and cytosol. Predicted to be active in early endosome; recycling endosome; and trans-Golgi network.
Source: NCBI Gene 55111 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 26 total
- MANE Select transcript:
NM_018049
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18211 |
| Approved symbol | PLEKHJ1 |
| Name | pleckstrin homology domain containing J1 |
| Location | 19p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ10297 |
| Ensembl gene | ENSG00000104886 |
| Ensembl biotype | protein_coding |
| OMIM | 617834 |
| Entrez | 55111 |
Gene structure
Transcript identifiers
Ensembl transcripts: 21 — 14 protein_coding, 5 retained_intron, 2 protein_coding_CDS_not_defined
ENST00000326631, ENST00000585423, ENST00000586497, ENST00000586608, ENST00000587394, ENST00000587962, ENST00000588356, ENST00000588450, ENST00000588545, ENST00000588633, ENST00000589097, ENST00000589791, ENST00000591099, ENST00000863429, ENST00000863430, ENST00000935575, ENST00000935576, ENST00000935577, ENST00000951302, ENST00000951303, ENST00000951304
RefSeq mRNA: 2 — MANE Select: NM_018049
NM_001300836, NM_018049
CCDS: CCDS12083, CCDS74251
Canonical transcript exons
ENST00000326631 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001288944 | 2236155 | 2236329 |
| ENSE00002780885 | 2233153 | 2233905 |
| ENSE00003504886 | 2235923 | 2235990 |
| ENSE00003560129 | 2235762 | 2235828 |
| ENSE00003610414 | 2234150 | 2234240 |
| ENSE00003623163 | 2233998 | 2234061 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 98.74.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 30.3455 / max 168.8527, expressed in 1819 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 178145 | 15.1496 | 1814 |
| 178144 | 11.9373 | 1783 |
| 178143 | 1.2066 | 720 |
| 178148 | 0.9456 | 438 |
| 178146 | 0.7762 | 492 |
| 178142 | 0.3029 | 133 |
| 178147 | 0.0273 | 5 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 98.74 | gold quality |
| duodenum | UBERON:0002114 | 97.64 | gold quality |
| transverse colon | UBERON:0001157 | 96.75 | gold quality |
| left testis | UBERON:0004533 | 96.69 | gold quality |
| right testis | UBERON:0004534 | 96.63 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 96.41 | gold quality |
| body of pancreas | UBERON:0001150 | 96.36 | gold quality |
| body of stomach | UBERON:0001161 | 96.20 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 96.09 | gold quality |
| apex of heart | UBERON:0002098 | 96.07 | gold quality |
| small intestine | UBERON:0002108 | 96.06 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 95.78 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 95.70 | gold quality |
| metanephros cortex | UBERON:0010533 | 95.68 | gold quality |
| ventricular zone | UBERON:0003053 | 95.60 | gold quality |
| fundus of stomach | UBERON:0001160 | 95.51 | gold quality |
| testis | UBERON:0000473 | 95.42 | gold quality |
| heart left ventricle | UBERON:0002084 | 95.30 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 95.07 | gold quality |
| stomach | UBERON:0000945 | 95.00 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 95.00 | gold quality |
| thyroid gland | UBERON:0002046 | 94.97 | gold quality |
| gastrocnemius | UBERON:0001388 | 94.89 | gold quality |
| intestine | UBERON:0000160 | 94.82 | gold quality |
| colon | UBERON:0001155 | 94.75 | gold quality |
| right adrenal gland | UBERON:0001233 | 94.72 | gold quality |
| ganglionic eminence | UBERON:0004023 | 94.61 | gold quality |
| granulocyte | CL:0000094 | 94.59 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 94.53 | gold quality |
| left adrenal gland | UBERON:0001234 | 94.40 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6524 | no | 348.30 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
36 targeting PLEKHJ1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-128-3P | 99.95 | 71.17 | 2484 |
| HSA-MIR-216A-3P | 99.95 | 71.19 | 2505 |
| HSA-MIR-3681-3P | 99.88 | 70.46 | 2254 |
| HSA-MIR-548D-3P | 99.87 | 70.67 | 4362 |
| HSA-MIR-548BB-3P | 99.86 | 70.58 | 4354 |
| HSA-MIR-548AC | 99.84 | 70.77 | 4351 |
| HSA-MIR-548H-3P | 99.84 | 70.80 | 4349 |
| HSA-MIR-548Z | 99.84 | 70.80 | 4349 |
| HSA-MIR-6764-5P | 99.75 | 67.89 | 2304 |
| HSA-MIR-10394-5P | 99.65 | 66.83 | 1852 |
| HSA-MIR-1205 | 99.65 | 66.76 | 1826 |
| HSA-MIR-9851-3P | 99.63 | 69.68 | 1110 |
| HSA-MIR-6833-5P | 99.50 | 68.93 | 1161 |
| HSA-MIR-1207-5P | 99.49 | 69.11 | 2983 |
| HSA-MIR-3911 | 99.38 | 66.95 | 1087 |
| HSA-MIR-593-5P | 99.34 | 69.50 | 965 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | plekhj1 | ENSDARG00000025593 |
| mus_musculus | Plekhj1 | ENSMUSG00000035278 |
| rattus_norvegicus | ENSRNOG00000075264 |
Paralogs (2): PHETA2 (ENSG00000177096), PHETA1 (ENSG00000198324)
Protein
Protein identifiers
Pleckstrin homology domain-containing family J member 1 — Q9NW61 (reviewed: Q9NW61)
Alternative names: Guanine nucleotide-releasing protein x
All UniProt accessions (5): Q9NW61, K7EIW9, K7EIZ3, K7ERH2, K7ERW3
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Expressed in testis and liver.
RefSeq proteins (2): NP_001287765, NP_060519* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001849 | PH_domain | Domain |
| IPR011993 | PH-like_dom_sf | Homologous_superfamily |
| IPR045188 | Boi1/Boi2-like | Family |
Pfam: PF00169
UniProt features (2 total): chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NW61-F1 | 91.16 | 0.82 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 111 (showing top):
GOBP_ENDOSOME_ORGANIZATION, GOBP_VESICLE_ORGANIZATION, GOBP_VESICLE_MEDIATED_TRANSPORT, GOCC_TRANS_GOLGI_NETWORK, KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN, GOBP_RECEPTOR_METABOLIC_PROCESS, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOBP_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI, GOBP_CYTOSOLIC_TRANSPORT, chr19p13, GOCC_RECYCLING_ENDOSOME, GOCC_ORGANELLE_SUBCOMPARTMENT, WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP, LU_EZH2_TARGETS_UP, GOBP_RECEPTOR_RECYCLING
GO Biological Process (3): receptor recycling (GO:0001881), endosome organization (GO:0007032), retrograde transport, endosome to Golgi (GO:0042147)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (8): early endosome (GO:0005769), trans-Golgi network (GO:0005802), cytosol (GO:0005829), recycling endosome (GO:0055037), endosome (GO:0005768), Golgi apparatus (GO:0005794), clathrin-coated vesicle (GO:0030136), cytoplasmic vesicle (GO:0031410)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 3 |
| endosome | 2 |
| endomembrane system | 2 |
| endocytosis | 1 |
| receptor metabolic process | 1 |
| endomembrane system organization | 1 |
| vesicle organization | 1 |
| intercellular transport | 1 |
| endosomal transport | 1 |
| cytosolic transport | 1 |
| binding | 1 |
| Golgi apparatus subcompartment | 1 |
| cellular anatomical structure | 1 |
| cytoplasmic vesicle | 1 |
| intracellular membrane-bounded organelle | 1 |
| coated vesicle | 1 |
| intracellular vesicle | 1 |
Protein interactions and networks
STRING
330 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PLEKHJ1 | SF3A2 | Q15428 | 488 |
| PLEKHJ1 | OR8K5 | Q8NH50 | 478 |
| PLEKHJ1 | ZNF574 | Q6ZN55 | 477 |
| PLEKHJ1 | OR5J2 | Q8NH18 | 469 |
| PLEKHJ1 | ZMYND19 | Q96E35 | 445 |
| PLEKHJ1 | PPP1R35 | Q8TAP8 | 419 |
| PLEKHJ1 | GPATCH1 | Q9BRR8 | 376 |
| PLEKHJ1 | ZNF460 | Q14592 | 376 |
| PLEKHJ1 | ZNF101 | Q8IZC7 | 371 |
| PLEKHJ1 | METTL23 | Q86XA0 | 370 |
| PLEKHJ1 | PSMG3 | Q9BT73 | 323 |
| PLEKHJ1 | RGL3 | Q3MIN7 | 323 |
| PLEKHJ1 | ATP5MJ | P56378 | 321 |
| PLEKHJ1 | PTP4A3 | O75365 | 320 |
| PLEKHJ1 | STX10 | O60499 | 310 |
IntAct
37 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PHETA2 | PLEKHJ1 | psi-mi:“MI:0915”(physical association) | 0.740 |
| PLEKHJ1 | PHETA1 | psi-mi:“MI:0915”(physical association) | 0.660 |
| GPX7 | GAK | psi-mi:“MI:0914”(association) | 0.640 |
| PIH1D2 | PLEKHJ1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PHETA1 | PLEKHJ1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LAGE3 | PLEKHJ1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NTAQ1 | PLEKHJ1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PHETA2 | SEMG1 | psi-mi:“MI:0914”(association) | 0.530 |
| PLEKHJ1 | OCRL | psi-mi:“MI:0914”(association) | 0.530 |
| PLEKHJ1 | DNMT3B | psi-mi:“MI:0915”(physical association) | 0.370 |
| PPBP | PLEKHJ1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| Xpo1 | IFT56 | psi-mi:“MI:0914”(association) | 0.350 |
| OCRL | ERC2 | psi-mi:“MI:0914”(association) | 0.350 |
| OCRL | MYO1C | psi-mi:“MI:0914”(association) | 0.350 |
| PHETA2 | NMT2 | psi-mi:“MI:0914”(association) | 0.350 |
| OCRL | AP2A1 | psi-mi:“MI:0914”(association) | 0.350 |
| PHETA1 | INPP5B | psi-mi:“MI:0914”(association) | 0.350 |
| OCRL | LTF | psi-mi:“MI:0914”(association) | 0.350 |
| PLEKHJ1 | AP3B1 | psi-mi:“MI:0914”(association) | 0.350 |
| PHETA2 | INPP5B | psi-mi:“MI:0914”(association) | 0.350 |
| PLEKHJ1 | DENND4B | psi-mi:“MI:0914”(association) | 0.350 |
| RNPS1 | WWP2 | psi-mi:“MI:0914”(association) | 0.350 |
| PINX1 | PLEKHJ1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PLEKHJ1 | KRT33B | psi-mi:“MI:0915”(physical association) | 0.000 |
| PLEKHJ1 | PHETA1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PLEKHJ1 | LAGE3 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (40): PLEKHJ1 (Affinity Capture-MS), PLEKHJ1 (Affinity Capture-MS), PLEKHJ1 (Affinity Capture-MS), PLEKHJ1 (Affinity Capture-MS), PLEKHJ1 (Affinity Capture-MS), PLEKHJ1 (Affinity Capture-MS), KRT33B (Affinity Capture-MS), PIH1D2 (Two-hybrid), WDYHV1 (Two-hybrid), FAM109B (Two-hybrid), LAGE3 (Two-hybrid), FAM109A (Two-hybrid), PLEKHJ1 (Affinity Capture-MS), PLEKHJ1 (Affinity Capture-MS), AP3B1 (Affinity Capture-MS)
ESM2 similar proteins: A6QLK6, O14508, O35717, O70277, O75382, O88582, O95057, P09851, P20936, P49138, P50904, P57790, P62993, P62994, P87379, Q05B84, Q07883, Q08012, Q13588, Q14145, Q16644, Q2T9Z7, Q3SYZ2, Q5PR73, Q5R4J7, Q5R6S2, Q5R774, Q5RKN4, Q5ZLD3, Q60631, Q66H84, Q66II3, Q684M4, Q6GPJ9, Q6TDP3, Q6YKA8, Q6ZPT1, Q7YRV6, Q861R0, Q8TC17
Diamond homologs: Q3ZCI3, Q5ZLT5, Q6P0G8, Q6P4L6, Q801R7, Q9D240, Q9NW61, D3ZL52, Q8BH49, Q8N4B1, A1CFB3, A1CYS1, A2CEA7, A2QNQ5, A7KAN4, B6RSP1, C4B4E5, O08967, O14827, O43739, P42331, P54644, P60669, P63034, P63035, P70392, P97694, P97696, Q00IB7, Q0CKU4, Q0UY53, Q14B98, Q15438, Q1RMU7, Q2KI41, Q2U0C3, Q4WID6, Q5B4C9, Q5U2Z7, Q6ICB4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
26 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 23 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
933 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:2233997:C:CA | donor_loss | 1.0000 |
| 19:2234012:T:A | donor_gain | 1.0000 |
| 19:2234024:T:A | donor_gain | 1.0000 |
| 19:2234059:TAG:T | acceptor_gain | 1.0000 |
| 19:2234062:C:CC | acceptor_gain | 1.0000 |
| 19:2235760:A:AC | donor_gain | 1.0000 |
| 19:2235761:C:CT | donor_gain | 1.0000 |
| 19:2236154:CCG:C | donor_gain | 1.0000 |
| 19:2233902:GGTCC:G | acceptor_loss | 0.9900 |
| 19:2233906:C:CA | acceptor_loss | 0.9900 |
| 19:2233906:C:CC | acceptor_gain | 0.9900 |
| 19:2233907:T:A | acceptor_loss | 0.9900 |
| 19:2234001:G:A | donor_gain | 0.9900 |
| 19:2234056:TCGTA:T | acceptor_gain | 0.9900 |
| 19:2234057:CGTAG:C | acceptor_gain | 0.9900 |
| 19:2234058:GTAG:G | acceptor_gain | 0.9900 |
| 19:2234060:AG:A | acceptor_gain | 0.9900 |
| 19:2234061:GC:G | acceptor_loss | 0.9900 |
| 19:2234162:AGAG:A | donor_gain | 0.9900 |
| 19:2234240:CCT:C | acceptor_loss | 0.9900 |
| 19:2234241:C:CC | acceptor_gain | 0.9900 |
| 19:2234241:C:G | acceptor_loss | 0.9900 |
| 19:2234242:T:G | acceptor_loss | 0.9900 |
| 19:2235746:C:A | donor_gain | 0.9900 |
| 19:2235757:CTCA:C | donor_gain | 0.9900 |
| 19:2235761:CT:C | donor_gain | 0.9900 |
| 19:2235761:CTG:C | donor_gain | 0.9900 |
| 19:2235761:CTGA:C | donor_gain | 0.9900 |
| 19:2235761:CTGAT:C | donor_gain | 0.9900 |
| 19:2235785:T:TA | donor_gain | 0.9900 |
AlphaMissense
975 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:2235947:G:C | F46L | 0.999 |
| 19:2235947:G:T | F46L | 0.999 |
| 19:2235949:A:G | F46L | 0.999 |
| 19:2235956:A:C | N43K | 0.999 |
| 19:2235956:A:T | N43K | 0.999 |
| 19:2234175:A:G | W99R | 0.998 |
| 19:2234175:A:T | W99R | 0.998 |
| 19:2234207:A:G | F88S | 0.998 |
| 19:2235948:A:G | F46S | 0.998 |
| 19:2234173:C:A | W99C | 0.997 |
| 19:2234173:C:G | W99C | 0.997 |
| 19:2235764:A:T | I76N | 0.997 |
| 19:2235818:G:T | A58D | 0.997 |
| 19:2235827:G:T | P55H | 0.997 |
| 19:2235951:A:T | L45H | 0.997 |
| 19:2235966:A:G | L40P | 0.997 |
| 19:2234038:A:G | L115P | 0.996 |
| 19:2234047:C:G | R112P | 0.996 |
| 19:2235815:A:G | L59P | 0.996 |
| 19:2235946:A:C | Y47D | 0.996 |
| 19:2235951:A:G | L45P | 0.996 |
| 19:2235821:C:T | G57E | 0.995 |
| 19:2235941:A:C | F48L | 0.995 |
| 19:2235941:A:T | F48L | 0.995 |
| 19:2235943:A:G | F48L | 0.995 |
| 19:2235949:A:T | F46I | 0.995 |
| 19:2235951:A:C | L45R | 0.995 |
| 19:2235957:T:A | N43I | 0.995 |
| 19:2236226:A:G | L8P | 0.995 |
| 19:2234150:C:A | S107I | 0.994 |
dbSNP variants (sampled 300 via entrez): RS1000189595 (19:2231792 C>G,T), RS1000622553 (19:2238022 G>C), RS1000720009 (19:2237005 G>C), RS1000978758 (19:2230011 A>G), RS1000979992 (19:2237137 G>A), RS1001011606 (19:2230177 G>C), RS1001237967 (19:2232123 G>A,T), RS1001289804 (19:2236120 C>G), RS1001607280 (19:2232241 C>G,T), RS1002208524 (19:2233149 C>A,T), RS1002287157 (19:2237002 C>A,G), RS1002359408 (19:2236739 C>A,G,T), RS1002396471 (19:2232339 A>C,T), RS1002710351 (19:2235525 A>G), RS1002871290 (19:2231487 C>G)
Disease associations
OMIM: gene MIM:617834 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003274_10 | Pulse pressure | 3.000000e-15 |
| GCST90020027_190 | Waist-hip index | 8.000000e-09 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0005763 | pulse pressure measurement |
| EFO:0007788 | BMI-adjusted waist-hip ratio |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB clinical annotations
1 annotations.
| Variant | Type | Level | Drugs | Phenotypes |
|---|---|---|---|---|
| rs740406 | Efficacy | 3 | candesartan | Hypertension |
PharmGKB variants
1 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs740406 | DOT1L, PLEKHJ1 | 3 | 3.00 | 1 | candesartan |
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | affects cotreatment, increases abundance, increases oxidation, affects expression | 2 |
| Ozone | affects cotreatment, increases oxidation, increases abundance, affects expression | 2 |
| alpha-pinene | increases oxidation, increases abundance, affects cotreatment | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| methacrylaldehyde | affects cotreatment, increases oxidation, increases abundance | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | increases expression | 1 |
| jinfukang | increases expression | 1 |
| Acetaminophen | affects response to substance | 1 |
| Acrolein | increases abundance, affects cotreatment, increases oxidation | 1 |
| Arsenic | affects methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Diazinon | increases methylation | 1 |
| Doxorubicin | decreases expression | 1 |
| Selenium | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Vitamin E | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Lactic Acid | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
| Volatile Organic Compounds | affects cotreatment, increases oxidation | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B3E2 | Abcam HEK293T PLEKHJ1 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.